Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Apr;42(4):971-3.
doi: 10.1128/AAC.42.4.971.

Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)

G B Mulamba  1 , A Hu, R F Azad, K P Anderson, D M Coen
Affiliations

Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)

G B Mulamba et al. Antimicrob Agents Chemother. 1998 Apr.

Abstract

A human cytomegalovirus mutant that was isolated for resistance (10-fold) to the antisense oligonucleotide fomivirsen (ISIS 2922) exhibited cross-resistance to a modified derivative of fomivirsen with an identical base sequence but little or no resistance to an oligonucleotide with an unrelated sequence. No changes in the mutant's DNA corresponding to the fomivirsen target sequence were found.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Procedures used to isolate a mutant resistant to fomivirsen. HFF, human foreskin fibroblasts; M.O.I., multiplicity of infection.
FIG. 2
FIG. 2
Susceptibilities to phosphorothioate oligonucleotides. Plaque reduction assays were performed as described in the text. Results presented are the averages of two separate experiments, each performed in duplicate. Similar results were obtained in a third experiment, in which different drug concentrations were used. Error bars represent standard errors of the means. Error bars are not presented for standard errors of the means that were too small to be visible on the plots.
See this image and copyright information in PMC

References

    1. Anderson K P, Fox M C, Brown-Driver V, Martin M J, Azad R F. Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob Agents Chemother. 1996;40:2004–2011. - PMC - PubMed
    1. Azad R F, Driver V B, Tanaka K, Crooke R M, Anderson K P. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother. 1993;37:1945–1954. - PMC - PubMed
    1. Chiou H C, Weller S K, Coen D M. Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors. Virology. 1985;145:213–226. - PubMed
    1. Coen D M. Enzymatic amplification of DNA by PCR: standard procedures and optimization. In: Ausubel F M, Brent R, Kingston R E, Moore D D, Smith J A, Seidman J G, Struhl K, editors. Current protocols in molecular biology. New York, N.Y: John Wiley & Sons; 1991.
    1. Coen D M. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antivir Res. 1991;15:287–300. - PubMed

Publication types

LinkOut - more resources